Investors Research Corp Haleon PLC Transaction History

Investors Research Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$8.02 - $8.67 $5,012 - $5,418	-625 Reduced 4.02%	14,923 $126,000
Q1 2023 May 11, 2023	SELL	$7.57 - $8.37 $1,892 - $2,092	-250 Reduced 1.58%	15,548 $126,000
Q4 2022 Feb 06, 2023	SELL	$5.96 - $8.06 $745 - $1,007	-125 Reduced 0.79%	15,798 $126,000
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $89,646 - $119,422	15,923 New	15,923 $97,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.